Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2017726759
Up to date per 11.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2017726759
Title / Product Name
VERFAHREN ZUR BEHANDLUNG VON HAUTKREBS DURCH VERABREICHUNG EINES PD-1-INHIBITORS
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2017726759
EP Publication Number
3455258
E-Number
1438143
Language
EN
PCT Number
US17032408
Publication Date
20.03.2019 A
13.10.2021 B1
Registration Date
13.10.2021
AT Publication Date
15.11.2021
Application Date
12.05.2017
Registration Number
-
Priorities
13.05.2016
US
201662335743 P
23.05.2016
US
201662340142 P
10.06.2016
US
201662348546 P
15.06.2016
US
201662350305 P
21.07.2016
US
201662364920 P
12.08.2016
US
201662374020 P
27.01.2017
US
201762451274 P
IPC
C07K 16/28 20060101AFI20171117BHEP
Maximum Duration of Protection
12.05.2037
Owner
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591
US
Representative
Representative
Patentanwaltskanzlei Matschnig & Forsthuber OG
Biberstraße 22
1010 Wien
AT
Inventor
LOWY, Israel
c/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road
Tarrytown, NY 10591
US
FURY, Matthew, G.
c/o Regeneron Pharmaceuticals Inc. 777 Old Saw Mill River Road
Tarrytown, NY 10591
US
Information about Fees
Click here to load the fees
see.ip - Details for VERFAHREN ZUR BEHANDLUNG VON HAUTKREBS DURCH VERABREICHUNG EINES PD-1-INHIBITORS